CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
12.28
+0.59 (5.05%)
At close: May 16, 2025, 4:00 PM
12.02
-0.26 (-2.10%)
After-hours: May 16, 2025, 7:52 PM EDT
CorMedix Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for CorMedix stock ranges from a low of $12 to a high of $18. The average analyst price target of $15 forecasts a 22.15% increase in the stock price over the next year.
Price Target: $15.00 (+22.15%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +22.15% | May 7, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +22.15% | May 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | -2.28% | Apr 9, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +22.15% | Apr 8, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | -2.28% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
147.44M
from 43.47M
Increased by 239.16%
Revenue Next Year
225.83M
from 147.44M
Increased by 53.17%
EPS This Year
0.69
from -0.30
EPS Next Year
1.54
from 0.69
Increased by 121.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 181.6M | 293.3M | 366.1M | ||
| Avg | 147.4M | 225.8M | 279.1M | ||
| Low | 125.4M | 147.2M | 134.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 317.6% | 98.9% | 62.1% | ||
| Avg | 239.2% | 53.2% | 23.6% | ||
| Low | 188.6% | -0.2% | -40.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.98 | 2.32 | 3.29 | ||
| Avg | 0.69 | 1.54 | 2.23 | ||
| Low | 0.52 | 0.77 | 0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 234.1% | 113.2% | ||
| Avg | - | 121.9% | 44.5% | ||
| Low | - | 11.5% | -48.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.